THE SOCIETAL IMPACT OF LENALIDOMIDE IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA IN GERMANY

被引：0
|
作者：
Hofmann, S. [1 ]
Seddik, A. [1 ]
机构：
[1] WifOR, Darmstadt, HE, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN216
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 50 条
  • [21] Current treatment patterns in multiple myeloma patients in Germany
    Raab, M. -S.
    Lebioda, A.
    Schoehl, M.
    Fink, L.
    Flinois, A.
    Schoen, P.
    Biedermann, P.
    Gonzalez-McQuire, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 79 - 79
  • [22] Pharmacokinetic and bioequivalence of lenalidomide in multiple myeloma patients
    Shen, Qi
    Gao, Tiantao
    Xiang, Jin
    Feng, Ping
    Liu, Xinghong
    Zheng, Li
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2023, 61 (04) : 181 - 188
  • [23] Update on the role of lenalidomide in patients with multiple myeloma
    Holstein, Sarah A.
    Suman, Vera J.
    McCarthy, Philip L.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2018, 9 (07) : 175 - 190
  • [24] Lenalidomide Maintenance Therapy in Patients with Multiple Myeloma
    Fillitz, M.
    Seebacher, A.
    Reisner, R.
    Pittermann-Hocker, E.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S90 - S90
  • [25] Population pharmacokinetics of lenalidomide in multiple myeloma patients
    Beatriz Guglieri-López
    Alejandro Pérez-Pitarch
    Dirk Jan A. R. Moes
    Begoña Porta-Oltra
    Mónica Climente-Martí
    Henk Jan Guchelaar
    Matilde Merino-Sanjuán
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 189 - 200
  • [26] Population pharmacokinetics of lenalidomide in multiple myeloma patients
    Guglieri-Lopez, Beatriz
    Perez-Pitarch, Alejandro
    Moes, Dirk Jan A. R.
    Porta-Oltra, Begona
    Climente-Marti, Monica
    Guchelaar, Henk Jan
    Merino-Sanjuan, Matilde
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 189 - 200
  • [27] Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
    Korde, Neha
    Roschewski, Mark
    Zingone, Adriana
    Kwok, Mary
    Manasanch, Elisabet E.
    Bhutani, Manisha
    Tageja, Nishant
    Kazandjian, Dickran
    Mailankody, Sham
    Wu, Peter
    Morrison, Candis
    Costello, Rene
    Zhang, Yong
    Burton, Debra
    Mulquin, Marcia
    Zuchlinski, Diamond
    Lamping, Liz
    Carpenter, Ashley
    Wall, Yvonne
    Carter, George
    Cunningham, Schuyler C.
    Gounden, Verena
    Sissung, Tristan M.
    Peer, Cody
    Maric, Irina
    Calvo, Katherine R.
    Braylan, Raul
    Yuan, Constance
    Stetler-Stevenson, Maryalice
    Arthur, Diane C.
    Kong, Katherine A.
    Weng, Li
    Faham, Malek
    Lindenberg, Liza
    Kurdziel, Karen
    Choyke, Peter
    Steinberg, Seth M.
    Figg, William
    Landgren, Ola
    JAMA ONCOLOGY, 2015, 1 (06) : 746 - 754
  • [28] Lenalidomide for Multiple Myeloma
    Bertolini, Francesco
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (06): : 573 - 573
  • [29] Lenalidomide in multiple myeloma
    Bagchi, Sanjit
    LANCET ONCOLOGY, 2007, 8 (10): : 872 - 872
  • [30] Lenalidomide in multiple myeloma
    Richardson, Paul G.
    Mitsiades, Constantine
    Hideshima, Teru
    Anderson, Kenneth C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (08) : 1165 - 1173
12345